000 01098 a2200301 4500
005 20250517152204.0
264 0 _c20180212
008 201802s 0 0 eng d
022 _a1347-5215
024 7 _a10.1248/bpb.b16-01006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHijioka, Masanori
245 0 0 _aDJ-1/PARK7: A New Therapeutic Target for Neurodegenerative Disorders.
_h[electronic resource]
260 _bBiological & pharmaceutical bulletin
_c2017
300 _a548-552 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAntiparkinson Agents
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aNeurodegenerative Diseases
_xdrug therapy
650 0 4 _aParkinson Disease
_xdrug therapy
650 0 4 _aProtein Deglycase DJ-1
_xdrug effects
700 1 _aInden, Masatoshi
700 1 _aYanagisawa, Daijiro
700 1 _aKitamura, Yoshihisa
773 0 _tBiological & pharmaceutical bulletin
_gvol. 40
_gno. 5
_gp. 548-552
856 4 0 _uhttps://doi.org/10.1248/bpb.b16-01006
_zAvailable from publisher's website
999 _c27128481
_d27128481